Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

Pharmacy Tech Giants Working Together to help Pharmacies Succeed |Pharmacy CrossRoads Feb 03, 2021

Show notes

In December of 2020 PioneerRx was acquired by RedSail Technologies. RedSail is a new company that has emerged as an industry powerhouse via its acquisition n in 2019 of QS1, one of the industries oldest and most well know pharmacy technology companies and now, PioneerRx. In this podcast Jeff Key, President of PioneerRx chats with Kraig McEwen, CEO of RedSail. During the interview together they outline the reasons the two companies have joined together and provide some insight into how they plan to work together to provide pharmacy owners with the tools, resources and information they need to succeed. One key thing they discuss is that they do not plan to merge QS1 and PioneerRx but allow them both to operate separately. McEwen outlines his professional background and assures current and potential PioneerRx users that Jeff Key and the PioneerRx management team, and philosophy, will remain unchanged. Jeff Key explains that PioneerRx hasd known for a year or more that in order to grow and improve that more resources would be needed and so PioneerRx and their parent company, Morris and Dickson Wholesale Drug, agreed to look for a business partner that could provide those resources. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

That Really Ticks Me Off | GameChangers Feb 02, 2021

Show notes

Lyme disease is a complex infection and post infection syndrome can lead to serious outcomes, including death. A new guideline was developed for the diagnosis and treatment of this infection. Spoon! This episode is accredited for CPE. Subscribe at CEimpact ( https://www.ceimpact.com/pharmacist ) and claim your CE today! Reference: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clinical Infectious Diseases, November 30, 2020. https://doi.org/10.1093/cid/ciaa1215. Accessed at https://www.idsociety.org/practice-guideline/lyme-disease/ CPE details for GameChangers Podcast February 2021 Learning Objective: Discuss treatment for different forms of lyme disease infections depending on the severity of symptoms 0107-0000-21-XXX-H01-P 0.2 CEU/2.0 Hrs (Knowledge) Initial Release Date: 02/23/21 Expiration Date: 02/23/24 Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy CrossRoads | Pharmacy Owner Richard Ost RPh Jan 29, 2021

Show notes

Today's special guest is Pharmacy owner & Community Champion Mr. Rich Ost, R.Ph., owner of Philadelphia Pharmacy located in Philadelphia, PA. Philadelphia Pharmacy is a well-known and respected establishment in downtown Philadelphia. It has been located on the corner of N. Front St. and E. Leigh for nearly 40 years and is owned by Richard Ost, RPh. In a city famous for buildings painted with colorful mural, the pharmacy boasts one of the city’s most notable. The corner locations is wrapped in a 3 story tall mural, on both the store front and side of the building that colorfully represents the evolution of medicine from botanicals to modern day prescriptions. In this episode of Pharmacy CrossRoads Ost tells Bruce Kneeland how, on Oct. 27, 2020, social unrest and rioting resulted in the looting of his pharmacy and several others in the City. Ost tells how, with the help of his staff, the community and suppliers the pharmacy was completely put back together and in a matter of days was once again serving the community. Ost also provides some words of advice for pharmacy owners on how they can prepare for this type of thing. Ost also share some tips on how he and his team, over the past years have worked to earn the trust, support and patronage of the community. He says it takes time, creativity and building relationships of trust best earned by treating people with respect, adjusting to ethnic needs and simply providing people with top notch care. Thank you to CPA the Compliant Pharmacy Alliance Cooperative for sponsoring the Pharmacy CrossRoads Podcast. CPA is proud to serve independent pharmacy owners. For over 25 years, we have made your business, our business. With over 2,000+ member pharmacies, CPA leverages an exceptional membership and our expertise to obtain market leading economics, services, and support. Being a 100% member-owned cooperative, there are no conflicts of interest. Learn more: https://members.compliantrx.com/ See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Data Science & A.I. | FutureDose Tech Jan 28, 2021

Show notes

In the future data science and artificial intelligence will be routinely used to give clinicians diagnostic recommendations; give scientists testable hypotheses they can confirm experimentally and offer them insights into safe and precise treatments; and give patients guidance on self-care, e.g., how to lead a healthy lifestyle and recognize disease early. Marinka Zitnik, PhD is an Assistant Professor of Biomedical Informatics, Harvard Medical School. Before joining Harvard, Dr. Zitnik was a postdoctoral fellow in Computer Science at Stanford University and was involved in projects at Chan Zuckerberg Biohub. Listen in as David and Marinka explain some AI concepts such as encoding, decoding, and embedding as well as discuss algorithms that can predict drug-drug interactions and identify medications that may be good candidates to treat COVID-19. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mark Cuban’s Cost Plus Drugs w/ CEO Dr. Alex Oshmyansky, MD, PhD Jan 27, 2021

Show notes

The new podcast called “Decoder with Nilay Patel” episode 1 @reckless released on Nov 10, 2020 with special guest MARK CUBAN ON AMERICA’S FUTURE & a short clip about Cost Plus Drugs. Alex Oshmyansky, MD, PhD is the CEO & Founder at Mark Cuban Cost Plus Drug Company. Dr. Alex along with strategic investor & business mogul Mark Cuban has launched Mark Cuban Cost Plus Drug Company, a pharmaceutical company that plans to make less expensive versions of selected generic drugs. The company's first drug is a generic version of albendazole, an antiparasitic drug used to treat hookworm. Treated early, two tablets will treat the infection; left untreated, cognitive defects and neurological problems can result. Cost Plus Drug Company is dedicated to producing low-cost versions of high-cost generic drugs. In this interview, Dr. Alex pledges to provide radical transparency in how they price their drugs. Dr. Alex has committed letting everyone know what it costs to manufacture, distribute, and market drugs to pharmacies. They will add a flat 15% margin to get wholesale prices. This will help to ensure they remain viable and profitable. There are no hidden costs, no middlemen, no rebates only available to insurance companies. Everybody gets the same low price for every drug they make. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

A Mother’s Strength & Resilience of a Daughter w/ Brain Cancer | Team Livi Jan 26, 2021

Show notes

Special Episode: A Mother's Strength & Resilience of a Daughter w/ Brain Cancer | Team Livi Todd Eury here, founder of the Pharmacy Podcast Network, with a first for our listeners since launching in 2009, I interview the most important person in healthcare, our patient. The mother of a little 10 year old girl, Livi, who has brain cancer. Livi's mother is Shannon Sealy, from my home town, Brownsville Pennsylvania. Help Livi Beat Brain Cancer CLICK HERE TO DONATE: https://www.gofundme.com/f/help-livi-beat-brain-cancer?rcid=bae1ad4959be44a795bf8566e381dc7a&utm_campaign=p_na+share-sheet&utm_medium=copy_link&utm_source=customer Data from this episode: Corticosteroids in brain cancer patients: benefits and pitfalls https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109638/ Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood: https://pubmed.ncbi.nlm.nih.gov/8487049/ See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Closer to the Heart | GameChangers Jan 26, 2021

Show notes

In December 2020, the American College of Cardiology published an Expert Consensus Decision Pathway for Antithrombotic Therapy in Patients undergoing Percutaneous Coronary Intervention. This guideline addresses a timely problem of patients on anticoagulation and antiplatelet therapy. This episode is accredited for CPE. Subscribe at CEimpact ( https://www.ceimpact.com/pharmacist ) and claim your CE today! Reference: 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. Dec 18, 2020. Epublished DOI: 10.1016/j.jacc.2020.09.011. Accessed at https://www.jacc.org/doi/10.1016/j.jacc.2020.09.011 CPE details for GameChangers Podcast January 2021 Learning Objective: Recommend an appropriate antithrombotic/anticoagulant regimen in a patient who has received percutaneous coronary intervention with stenting 0107-0000-21-079-H01-P 0.2 CEU/2.0 Hrs (Knowledge) Initial Release Date: 01/25/21 Expiration Date: 01/26/24 Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacist’s Guide to COVID-19 Testing | Beyond the Sig Jan 25, 2021

Show notes

On this episode of Beyond the Sig, third-year student pharmacist Brooke Kulusich chats with Garrett Sipes, PharmD of Chambers’ Apothecary in Chambersburg, Pennsylvania. Recently, this pharmacy has successfully implemented COVID-19 testing. Garrett walks us through this process step-by-step and shares valuable lessons learned for pharmacists looking to get involved. All the PPA Podcasts: https://www.papharmacists.com/page/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Pharmacist’s Impact: Reimagined the Life Sciences Beyond COVID-19 Jan 20, 2021

Show notes

Today's special guest is Susan Garfield, DrPH, Principal | Commercial Lead | Health Sciences and Wellness Sector with Ernst & Young LLP. Susan is an author on the study titled: Reimagined the Life Sciences Beyond COVID-19 Summary: From payer-mix changes, to pricing and profitability concerns, COVID-19 has made the biopharma industry fraught with market and other pressures. However, these circumstances have also presented new opportunities, including accelerated adoption of digital tools and approaches. This was all made clear when we, in association with EY, surveyed 550+ biopharma executives - from R&D to commercial – to gain practical insights on the current state and long-term outlook for the industry. This new free report ‘Beyond COVID-19: Life sciences reimagined’ highlights key findings from our analysis and is intended to help establish a framework for more patient-focused, sustainable care delivery post-crisis. Download this 30+ page report and: See the impact of COVID-19 across the product lifecycle, highlighting commercial, HCP needs and relationships, marketing and the sales model, patient engagement, medical affairs and R&D – with one of the largest surveys of senior-pharma professionals during the pandemic Hear from pharma leaders who are plotting the industry’s re-mergence strategies into the “new normal” Benchmark your own response and experience to COVID-19 against hundreds of industry peers Download this 30+ page report for free here. Insights from industry leaders, include: Karan Arora, Chief Commercial Digital Officer, AstraZeneca Chetak Buaria, Global Head of Customer Engagement & Channel Evolution, Biopharma Global, Merck Kabir Nath, President, Otsuka North America Pharmaceutical Business Harmony Garges, CMO, ViiV Healthcare See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

My Shot! | GameChangers Jan 19, 2021

Show notes

The unbelievable happened in 2020 - a vaccine was developed with high efficacy within 12 months for a novel virus! In December two vaccines for the prevention of the SARS-CoV-2 virus were approved through Emergency Use Authorization in the US. Is it time to get a shot? This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! Reference: Polack F, Thomas S, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. NEJM. Dec 10, 2020. DOI: 10.1056/NEJM2034577 Baden L, El Sahly H, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. NEJM. Dec 30, 2020. DOI: 10.1056/NEHMoa2035389 ACIP Recommendations: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Related Podcasts